Cancer is increasingly being treated as a chronic condition for people. The number of cancer survivors is rising quickly in the West due to rising incidence rates, faster detection, and better treatments. While most patients first prioritise life expectancy, quality of life (QOL) eventually takes on greater significance. However, more patients are dealing with the longterm adverse effects of cancer and its treatment, which can have a detrimental influence on patients' QOL, as a result of the increased incidence of cancer. Chemotherapy-induced peripheral neuropathy (CIPN), which can happen after using certain chemotherapeutic medicines like taxanes and platinum derivatives, is one of those potential side effects.

.